CHICAGO (Reuters) - A new understanding of the link between diabetes and obesity may help drug companies design safer versions of treatments like GlaxoSmithKline's Avandia, U.S. researchers said on Wednesday. The researchers had believed Avandia and Takeda Pharmaceutical Co's Actos work by stimulating a protein known as PPAR-gamma. Now the team thinks the drugs also act on the ...

Federal health officials say new patients should not be enrolled in a study of GlaxoSmithKline's controversial diabetes pill Avandia, after experts last week said the drug increases heart risks. The Food and Drug Administration issued a hold on the study to update researchers ...

Drugmaker Bristol-Myers Squibb Co. is expected to focus on a raft of recent positive research data and plans to seek approval for several drugs when it reports its second-quarter results before the stock market opens Thursday. WHAT TO WATCH FOR: Analysts anticipate detailed updates on several key ...

CHICAGO (Reuters) - The U.S. Food and Drug Administration has warned Abbott Laboratories' diabetes care unit about manufacturing problems at its Alameda, California plant, a letter released Tuesday said. In a letter dated July 2, FDA said its inspectors found Abbott's Freestyle and Navigator blood glucose monitoring products were adulterated and not conforming with codes for good quality system ...

The following recalls have been announced: _ Good Health Inc., of Canutillo, Texas, is recalling select lots of the dietary supplement Vialipro because they could contain a compound that is chemically similar to the erectile dysfunction drug sildenafil. This compound could interact with nitrates found in some prescription drugs for diabetes, high blood pressure, high cholesterol ...

A majority of members of a key advisory committee recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale. Most of the panel's members agreed that the drug increases the risk of heart problems, but only 12 of the 33-member expert panel voted to remove GlaxoSmithKline's one-time blockbuster ...

Diabetes drug Avandia faces a moment of truth Wednesday, when a committee will decide whether to recommend pulling it from the market because it has been associated with increased heart problems. The committee, convened at the request of the Food and Drug Administration, began its work on Tuesday as two US senators said Avandia manufacturer GlaxoSmithKline (GSK) hid studies showing ...

British pharmaceutical giant GlaxoSmithKline hid the dangers of its top-selling diabetes drug Avandia and secretly wrote scientific articles about it, two US lawmakers charged Tuesday. The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting of experts who will weigh whether to pull Avandia from the market over safety concerns. In a letter dated Monday and ...

UK pharmaceutical giant GlaxoSmithKline kept the dangers of its top-selling diabetes drug Avandia out of the public eye and ghostwrote scientific articles about it, US lawmakers charged Tuesday. The allegations came as the Food and Drug Administration (FDA) opened a two-day meeting of experts, who will weigh whether to pull Avandia from the market over safety concerns. In a letter ...

Indian scientists said Tuesday they had made a breakthrough that could lead to diabetics needing to inject themselves only once a month or less, rather than every day. Researchers at the National Institute of Immunology in New Delhi said they had successfully concluded a two-year trial on mice, rats and rabbits of a drug which slowly releases insulin into the ...